Jordan N - Search Results

1

Abnormal stimulation of the thyrotrophin receptor during gestation.

Rodien P, Jordan N, Lefèvre A, Royer J, Vasseur C, Savagner F, Bourdelot A, Rohmer V. Rodien P, et al. Among authors: jordan n. Hum Reprod Update. 2004 Mar-Apr;10(2):95-105. doi: 10.1093/humupd/dmh008. Hum Reprod Update. 2004. PMID: 15073140 Review.

2

Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo.

Starkey KJ, Janezic A, Jones G, Jordan N, Baker G, Ludgate M. Starkey KJ, et al. Among authors: jordan n. J Mol Endocrinol. 2003 Jun;30(3):369-80. doi: 10.1677/jme.0.0300369. J Mol Endocrinol. 2003. PMID: 12790806

3

Potent thyrotrophin receptor-blocking antibodies: a cause of transient congenital hypothyroidism and delayed thyroid development.

Evans C, Jordan NJ, Owens G, Bradley D, Ludgate M, John R. Evans C, et al. Among authors: jordan nj. Eur J Endocrinol. 2004 Mar;150(3):265-8. doi: 10.1530/eje.0.1500265. Eur J Endocrinol. 2004. PMID: 15012609

4

The W546X mutation of the thyrotropin receptor gene: potential major contributor to thyroid dysfunction in a Caucasian population.

Jordan N, Williams N, Gregory JW, Evans C, Owen M, Ludgate M. Jordan N, et al. J Clin Endocrinol Metab. 2003 Mar;88(3):1002-5. doi: 10.1210/jc.2002-021301. J Clin Endocrinol Metab. 2003. PMID: 12629076

5

A luminescent bioassay for thyroid blocking antibodies.

Jordan NJ, Rinderle C, Ashfield J, Morgenthaler NG, Lazarus J, Ludgate M, Evans C. Jordan NJ, et al. Clin Endocrinol (Oxf). 2001 Mar;54(3):355-64. doi: 10.1046/j.1365-2265.2001.01193.x. Clin Endocrinol (Oxf). 2001. PMID: 11298088

6

Demonstration of immunoglobulin G, A, and E autoantibodies to the human thyrotropin receptor using flow cytometry.

Metcalfe R, Jordan N, Watson P, Gullu S, Wiltshire M, Crisp M, Evans C, Weetman A, Ludgate M. Metcalfe R, et al. Among authors: jordan n. J Clin Endocrinol Metab. 2002 Apr;87(4):1754-61. doi: 10.1210/jcem.87.4.8411. J Clin Endocrinol Metab. 2002. PMID: 11932312

7

The antiepidermal growth factor receptor agent gefitinib (ZD1839/Iressa) improves antihormone response and prevents development of resistance in breast cancer in vitro.

Gee JM, Harper ME, Hutcheson IR, Madden TA, Barrow D, Knowlden JM, McClelland RA, Jordan N, Wakeling AE, Nicholson RI. Gee JM, et al. Among authors: jordan n. Endocrinology. 2003 Nov;144(11):5105-17. doi: 10.1210/en.2003-0705. Epub 2003 Aug 7. Endocrinology. 2003. PMID: 12960029

8

ZIP7-mediated intracellular zinc transport contributes to aberrant growth factor signaling in antihormone-resistant breast cancer Cells.

Taylor KM, Vichova P, Jordan N, Hiscox S, Hendley R, Nicholson RI. Taylor KM, et al. Among authors: jordan n. Endocrinology. 2008 Oct;149(10):4912-20. doi: 10.1210/en.2008-0351. Epub 2008 Jun 26. Endocrinology. 2008. PMID: 18583420

9

Epithelial protein lost in neoplasm-α (EPLIN-α) is a potential prognostic marker for the progression of epithelial ovarian cancer.

Liu R, Martin TA, Jordan NJ, Ruge F, Ye L, Jiang WG. Liu R, et al. Int J Oncol. 2016 Jun;48(6):2488-96. doi: 10.3892/ijo.2016.3462. Epub 2016 Mar 29. Int J Oncol. 2016. PMID: 27035883

10

Chronic exposure to fulvestrant promotes overexpression of the c-Met receptor in breast cancer cells: implications for tumour-stroma interactions.

Hiscox S, Jordan NJ, Jiang W, Harper M, McClelland R, Smith C, Nicholson RI. Hiscox S, et al. Endocr Relat Cancer. 2006 Dec;13(4):1085-99. doi: 10.1677/erc.1.01270. Endocr Relat Cancer. 2006. PMID: 17158755

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

484 results

Search Page